University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 22 of 26

COMPLETED Phase 2

Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA

NCT01521949

COMPLETED

Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss

NCT01448694

COMPLETED

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

NCT01456962

TERMINATED

Predicting Lung Injury From Transfusion in Patients With Liver Disease

NCT01756690

COMPLETED NA

Environmental Influences on Early Childhood Obesity

NCT02703688

COMPLETED NA

Timing Estrogen After MenoPaUSe

NCT01605071

COMPLETED

Protein and Ultrasound Indicators of Preterm Birth

NCT01412931

COMPLETED NA

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

NCT01427504

COMPLETED NA

Promoting Behavioral Change for Oral Health in American Indian Mothers and Children

NCT01116726

COMPLETED

A Continuous, Non-Invasive, Real-time Method for Estimating and Predicting Intracranial Hypertension

NCT01448681

COMPLETED Phase 3

Vitamin D and Arterial Function in Patients With Chronic Kidney Disease

NCT01384539

COMPLETED Phase 2

Nicotinic Receptors and Schizophrenia

NCT01400477

COMPLETED NA

Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma

NCT01460810

COMPLETED

Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery

NCT01382758

COMPLETED NA

Progressive Rehabilitation Following Total Knee Arthroplasty

NCT01537328

TERMINATED NA

Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control

NCT01916590

TERMINATED Phase 2

Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension

NCT01409031

TERMINATED Phase 3

INR-Triggered Transfusion In GI Bleeders From ER

NCT01461889

TERMINATED NA

Intra Uterine Device Insertion in Nulliparous Women

NCT01422226

COMPLETED NA

Statin Discontinuation in Advanced Illness

NCT01415934

COMPLETED Phase 3

Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes

NCT01816165

COMPLETED NA

Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

NCT01381016

COMPLETED Phase 4

The Health Influences of Puberty (HIP) Study

NCT01775813

COMPLETED Phase 1

Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E

NCT01700426

COMPLETED

On-site Cytopathology EUS-FNA

NCT01386931

COMPLETED

Functional Connectivity Parkinson Disease

NCT01798563

COMPLETED NA

Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

NCT01580813

COMPLETED Phase 4

Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes

NCT01813929

COMPLETED NA

Improving Function, Participation and Function After Acute Hospitalization in Older Adults

NCT01872637

TERMINATED Phase 4

Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation

NCT01235910

COMPLETED Phase 1

Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer

NCT01255800

COMPLETED NA

RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence

NCT01409421

COMPLETED Phase 3

Preventing Caries in Preschoolers: Testing a Unique Service Delivery Model in American Indian Head Start Programs

NCT01116739

COMPLETED NA

Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers

NCT02101723

COMPLETED Phase 2

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

NCT01409915

COMPLETED

Adiponectin and Ethnic Differences in Insulin Resistance

NCT01831102

COMPLETED NA

Zinc and Iron Bioavailability From Biofortified Pearl Millet

NCT01783067

COMPLETED NA

Improving Function After Knee Arthroplasty With Weight-Bearing Biofeedback

NCT01333189

COMPLETED Phase 3

Ketamine Versus Co-administration of Ketamine and Propofol for Procedural Sedation in a Pediatric Emergency Department

NCT01387139

COMPLETED NA

The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population

NCT02616458

COMPLETED Phase 3

Laparoscopic Cholecystectomy And Capacitive Coupling - Coag Versus Blend Mode Causing Thermal Injury at Port Site Skin

NCT01664806

COMPLETED Phase 1

Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents

NCT01262300

COMPLETED NA

Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes

NCT01364584

COMPLETED Phase 1

The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes

NCT01319331

COMPLETED

Effects of an Adapted Ski/Snowboarding Program on Quality of Life in Children With Physical Disabilities

NCT02110290

COMPLETED NA

Uric Acid and the Endothelium in CKD

NCT01228903

COMPLETED NA

Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders

NCT04208243

COMPLETED Phase 2

Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

NCT01209442

COMPLETED

Outcomes of the Evans Calcaneal Lengthening Based on Bone Grafting Material

NCT02075853

COMPLETED Phase 4

Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital

NCT01203774

← Previous Page 22 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.